Table 5.
HRs and 95% CI for two consecutive changes of DM treatment by PCa diagnosis and PCa treatments
| Multivariate analysis* | |||
| HR | 95% CI | ||
| PCa diagnosis | No PCa | 1.00 | (Ref) |
| PCa | 1.75 | 1.38 to 2.22 | |
| PCa treatment | No PCa | 1.00 | (Ref) |
| No ADT | 1.40 | 1.03 to 1.92 | |
| AA | 0.91 | 0.29 to 2.82 | |
| GnRH | 3.08 | 2.14 to 4.44 | |
| PCa diagnosis in relation to prior change in T2DM treatment | No PCa | 1.00 | (Ref) |
| PCa prior to one change | 1.09 | 0.78 to 1.54 | |
| PCa after one change | 3.59 | 2.61 to 4.93 | |
*Multivariate analysis with age as time scale and adjusted for education status and initial diabetes treatment.
AA, antiandrogen; ADT, androgen deprivation therapy; GnRH, gonadotropin-releasing hormone agonist; PCa, prostate cancer; T2DM, type 2 diabetes mellitus.